D-Index & Metrics Best Publications
Hisatomi Arima

Hisatomi Arima

Fukuoka University
Japan

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Stroke
  • Surgery

His main research concerns Internal medicine, Blood pressure, Randomized controlled trial, Surgery and Stroke. The Internal medicine study combines topics in areas such as Endocrinology and Cardiology. His research integrates issues of Contraindication and Intensive care medicine in his study of Blood pressure.

Hisatomi Arima has researched Randomized controlled trial in several fields, including Anesthesia, Clinical trial, Diabetes mellitus, Guideline and Intracerebral hemorrhage. Hisatomi Arima combines subjects such as Odds ratio, Disease and Confidence interval with his study of Surgery. His biological study spans a wide range of topics, including Myocardial infarction, Vascular disease, Prospective cohort study, Perindopril and Indapamide.

His most cited work include:

  • CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea (807 citations)
  • Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage (802 citations)
  • Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. (573 citations)

What are the main themes of his work throughout his whole career to date?

Hisatomi Arima mainly focuses on Internal medicine, Blood pressure, Stroke, Cardiology and Surgery. His research combines Diabetes mellitus and Internal medicine. His studies in Blood pressure integrate themes in fields like Anesthesia, Randomized controlled trial, Confidence interval and Clinical trial.

His Stroke study incorporates themes from Physical therapy, Pediatrics, Myocardial infarction and Epidemiology. His work in Cardiology addresses issues such as Body mass index, which are connected to fields such as Obesity. Hisatomi Arima interconnects Cancer, Renal function, Kidney disease and Risk factor in the investigation of issues within Surgery.

He most often published in these fields:

  • Internal medicine (83.75%)
  • Blood pressure (66.25%)
  • Stroke (56.67%)

What were the highlights of his more recent work (between 2016-2020)?

  • Stroke (56.67%)
  • Internal medicine (83.75%)
  • Blood pressure (66.25%)

In recent papers he was focusing on the following fields of study:

Hisatomi Arima mainly investigates Stroke, Internal medicine, Blood pressure, Cardiology and Pediatrics. His Stroke research includes themes of Prospective cohort study, Randomized controlled trial and Myocardial infarction. His Randomized controlled trial research integrates issues from Physical therapy and Cerebral blood flow.

Hisatomi Arima studied Internal medicine and Surgery that intersect with Modified Rankin Scale. His Blood pressure study combines topics in areas such as Uric acid, Febuxostat and Pharmacology. His Cardiology research incorporates elements of Body mass index, Obesity, Waist and Epidemiology.

Between 2016 and 2020, his most popular works were:

  • Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies (385 citations)
  • Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies (385 citations)
  • Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data (98 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Stroke
  • Surgery

Hisatomi Arima focuses on Stroke, Thrombolysis, Intracerebral hemorrhage, Randomized controlled trial and Incidence. The concepts of his Stroke study are interwoven with issues in Lower risk, Myocardial infarction and Substance abuse. The study incorporates disciplines such as Supine position, Fibrinolytic agent, Blood pressure and Cerebral perfusion pressure in addition to Randomized controlled trial.

His work deals with themes such as Anesthesia, Clinical trial, Contraindication, Guideline and Modified Rankin Scale, which intersect with Fibrinolytic agent. His Modified Rankin Scale research is within the category of Internal medicine. His work carried out in the field of Incidence brings together such families of science as Pediatrics and Cohort.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea

R. D. McEvoy;N. A. Antic;E. Heeley;Y. Luo.
The New England Journal of Medicine (2016)

1513 Citations

Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage

Craig S. Anderson;Emma Heeley;Yining Huang;Jiguang Wang.
The New England Journal of Medicine (2013)

1245 Citations

Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial.

Craig S Anderson;Yining Huang;Ji Guang Wang;Hisatomi Arima;Hisatomi Arima.
Lancet Neurology (2008)

1037 Citations

Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality

Josef Coresh;Tanvir Chowdhury Turin;Kunihiro Matsushita;Yingying Sang.
JAMA (2014)

778 Citations

Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies

Angela M. Wood;Stephen Kaptoge;Adam S. Butterworth;Peter Willeit.
The Lancet (2018)

698 Citations

Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes

Sophia Zoungas;John Chalmers;Bruce Neal;Laurent Billot.
The New England Journal of Medicine (2014)

694 Citations

Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data

Johan Sundström;Johan Sundström;Hisatomi Arima;Mark Woodward;Mark Woodward;Rod Jackson.
The Lancet (2014)

617 Citations

Trends in the Incidence, Mortality, and Survival Rate of Cardiovascular Disease in a Japanese Community The Hisayama Study

Michiaki Kubo;Yutaka Kiyohara;Isao Kato;Yumihiro Tanizaki.
Stroke (2003)

566 Citations

Incidence and risk factors for subtypes of cerebral infarction in a general population: the Hisayama study.

Yumihiro Tanizaki;Yutaka Kiyohara;Isao Kato;Hiromitsu Iwamoto.
Stroke (2000)

470 Citations

Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke

Craig S. Anderson;Thompson Robinson;Richard I. Lindley;Hisatomi Arima.
The New England Journal of Medicine (2016)

375 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Hisatomi Arima

Craig S. Anderson

Craig S. Anderson

George Institute for Global Health (UK)

Publications: 223

Mark Woodward

Mark Woodward

Imperial College London

Publications: 140

John Chalmers

John Chalmers

George Institute for Global Health (UK)

Publications: 110

Toshiharu Ninomiya

Toshiharu Ninomiya

Kyushu University

Publications: 99

Yutaka Kiyohara

Yutaka Kiyohara

Kyushu University

Publications: 87

Hirotsugu Ueshima

Hirotsugu Ueshima

Shiga University of Medical Science

Publications: 83

Katsuyuki Miura

Katsuyuki Miura

Shiga University of Medical Science

Publications: 80

Philip M.W. Bath

Philip M.W. Bath

University of Nottingham

Publications: 77

Tomonori Okamura

Tomonori Okamura

Keio University

Publications: 75

Giuseppe Mancia

Giuseppe Mancia

University of Milano-Bicocca

Publications: 74

Steven M. Greenberg

Steven M. Greenberg

Harvard University

Publications: 68

Takayoshi Ohkubo

Takayoshi Ohkubo

Teikyo University

Publications: 61

Hiroyasu Iso

Hiroyasu Iso

Osaka University

Publications: 60

Jonathan Rosand

Jonathan Rosand

Harvard University

Publications: 60

Vlado Perkovic

Vlado Perkovic

George Institute for Global Health (Australia)

Publications: 51

Sophia Zoungas

Sophia Zoungas

Monash University

Publications: 48

Trending Scientists

Filip De Turck

Filip De Turck

Ghent University

Moritz Hardt

Moritz Hardt

Max Planck Institute for Intelligent Systems

Ivan Vulić

Ivan Vulić

University of Cambridge

Pere-Lluís Cabot

Pere-Lluís Cabot

University of Barcelona

Hideo Takahashi

Hideo Takahashi

University of Tokyo

Bruno P. A. Cammue

Bruno P. A. Cammue

KU Leuven

Charles A. Specht

Charles A. Specht

University of Massachusetts Medical School

J. Paul Knox

J. Paul Knox

University of Leeds

Wolfgang Huber

Wolfgang Huber

European Bioinformatics Institute

Allan B. Okey

Allan B. Okey

University of Toronto

Eric J. Arts

Eric J. Arts

University of Western Ontario

Benjamín S. Gimeno

Benjamín S. Gimeno

Complutense University of Madrid

Maria Luisa Scattoni

Maria Luisa Scattoni

Istituto Superiore di Sanità

Johannes Rojahn

Johannes Rojahn

George Mason University

Wendy A. Goldberg

Wendy A. Goldberg

University of California, Irvine

Per Soelberg Sørensen

Per Soelberg Sørensen

University of Copenhagen

Something went wrong. Please try again later.